Autologous haematopoietic stem cell transplantation (HSCT) has proved efficacious in treating patients with systemic sclerosis, but different regimens have different associated toxicities and ...
5d
New evidence on graft-versus-host disease prevention in stem cell transplants from unrelated donors
Anti-T-lymphocyte globulin (ATLG) for the prevention of graft-versus-host disease (GvHD) reduces complications and ...
Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — Allogeneic hematopoietic stem cell transplantation appeared effective for patients with ...
Please provide your email address to receive an email when new articles are posted on . Older patients with myelodysplastic syndrome who underwent donor-matched allogeneic hematopoietic stem cell ...
Haematopoietic stem cell transplantation for refractory Crohn's disease has the potential to halt therapy-resistant inflammation. Hawkey et al. argue that HSCT does not offer sustained benefit based ...
MedPage Today on MSN
Stem cell transplant for sickle cell disease more cost-effective than gene therapy
More quality-adjusted life-years with gene therapy, but at a much higher cost ...
Upfront hematopoietic stem cell transplantation (HSCT) is more cost-effective than delayed HSCT for patients with intermediate-risk acute myeloid leukemia in remission, with higher incremental net ...
A phone-delivered positive psychological intervention for allogeneic hematopoietic stem cell transplant (HSCT) survivors was feasible and showed preliminary efficacy in a pilot randomized clinical ...
Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly approved agent for allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...
"AIC is important in aAA patients as it disturbs the precise understanding and thus management of these patients…Diagnosis and pathophysiological interpretation of the exact situation is rather ...
UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel)Securing Canadian rights to a proprietary ...
LONDON-- (BUSINESS WIRE)--Technavio has been monitoring the hematopoietic stem cells transplantation (HSCT) market and it is poised to grow by USD 4.64 billion during 2020-2024, progressing at a CAGR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results